Benefit-Risk Assessment in Drug Development - DTU Orbit

‹ Back to search result

Benefit-Risk Assessment in Drug Development

Project: PhD

With the same participants

Identification of the features contributing to immunodominance
Project: PhD
Analysis of the T cell immune response in Yellow fever virus and HIV infections
Project: PhD
Prediction of antigen_BCR interactions based on high throughput peptide chip data and prediction of MHC-peptide-TCR Interactions
Project: PhD
Bioinformatics approaches to identify antimicrobial, virulence and other important genes in bacteria
Project: PhD
Target profilling of drugs
Project: PhD
Prediction of Bacterial Pathogenicity
Project: PhD
Client-Server Rapid Taxonomy Identification
Project: PhD
Epitope prediction methods
Project: PhD
A quantitative description of subcutaneos injections: from needle to clinical effect
Project: PhD
Optimizing and Broadening the Breadth of a VAR2CSA DBL4 Based Placental Malaria Vaccine by in silico Sequence Analysis
Project: PhD

Sarac, Sinan (Phd Student)
Mosekilde, Erik (Supervisor)
Thirstrup, Steffen (Supervisor)
Mosekilde, Erik (Main Supervisor)
Lund, Ole (Examiner)
Helboe, Per (Examiner)
Lund, Ole (Examiner)

View graph of relations

Status	Completed
Period	01-12-08 → 30-04-12

Financing source	Internal funding (public)
Research programme	ErhvervsPhD-ordningen VTU

Publications

Benefit-Risk Assessment in Drug Development
Publication: Research › Ph.d. thesis – Annual report year: 2012

ID: 2327732